• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

桑菊清肺汤对慢性阻塞性肺疾病防治中肺部微生物群的影响。

The impact of Sangju Qingjie Decoction on the pulmonary microbiota in the prevention and treatment of chronic obstructive pulmonary disease.

机构信息

Clinical Pharmacy, Xiangtan Center Hospital, Xiangtan, Hunan, China.

Pulmonary and Critial Care Medicine, Zhongshan Hospital of Traditional Chinese Medicine, Zhongshan, Guangdong, China.

出版信息

Front Cell Infect Microbiol. 2024 Apr 30;14:1379831. doi: 10.3389/fcimb.2024.1379831. eCollection 2024.

DOI:10.3389/fcimb.2024.1379831
PMID:38746785
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11091421/
Abstract

OBJECTIVE

Exploring the effect of SJQJD on the pulmonary microbiota of chronic obstructive pulmonary disease (COPD) rats through 16S ribosomal RNA (rRNA) sequencing.

METHODS

A COPD rat model was constructed through smoking and lipopolysaccharide (LPS) stimulation, and the efficacy of SJQJD was evaluated by hematoxylin and eosin (H&E) staining and Enzyme-Linked Immunosorbnent Assay (ELISA). The alveolar lavage fluid of rats was subjected to 16S rRNA sequencing. The diversity of lung microbiota composition and community structure was analyzed and differential microbiota were screened. Additionally, machine learning algorithms were used for screening biomarkers of each group of the microbiota.

RESULTS

SJQJD could improve lung structure and inflammatory response in COPD rats. 16s rRNA sequencing analysis showed that SJQJD could significantly improve the abundance and diversity of bacterial communities in COPD rats. Through differential analysis and machine learning methods, potential microbial biomarkers were identified as , , and .

CONCLUSION

SJQJD could improve tissue morphology and local inflammatory response in COPD rats, and its effect may be related to improve pulmonary microbiota.

摘要

目的

通过 16S 核糖体 RNA(rRNA)测序探讨 SJQJD 对慢性阻塞性肺疾病(COPD)大鼠肺部微生物群的影响。

方法

通过吸烟和脂多糖(LPS)刺激构建 COPD 大鼠模型,通过苏木精和伊红(H&E)染色和酶联免疫吸附试验(ELISA)评估 SJQJD 的疗效。对大鼠肺泡灌洗液进行 16S rRNA 测序。分析肺微生物群落组成和结构的多样性,并筛选差异微生物群。此外,还使用机器学习算法筛选每组微生物的生物标志物。

结果

SJQJD 可改善 COPD 大鼠的肺结构和炎症反应。16s rRNA 测序分析表明,SJQJD 可显著改善 COPD 大鼠肺部细菌群落的丰度和多样性。通过差异分析和机器学习方法,鉴定出潜在的微生物生物标志物为、、和。

结论

SJQJD 可改善 COPD 大鼠的组织形态和局部炎症反应,其作用可能与改善肺部微生物群有关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1ef/11091421/f2a1f7aea09d/fcimb-14-1379831-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1ef/11091421/a2e2bd1d1814/fcimb-14-1379831-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1ef/11091421/3ddfd4f0cd25/fcimb-14-1379831-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1ef/11091421/19bd36511779/fcimb-14-1379831-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1ef/11091421/1b7200a9c444/fcimb-14-1379831-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1ef/11091421/81d9be265564/fcimb-14-1379831-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1ef/11091421/f9e7beacbaf1/fcimb-14-1379831-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1ef/11091421/f2a1f7aea09d/fcimb-14-1379831-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1ef/11091421/a2e2bd1d1814/fcimb-14-1379831-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1ef/11091421/3ddfd4f0cd25/fcimb-14-1379831-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1ef/11091421/19bd36511779/fcimb-14-1379831-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1ef/11091421/1b7200a9c444/fcimb-14-1379831-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1ef/11091421/81d9be265564/fcimb-14-1379831-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1ef/11091421/f9e7beacbaf1/fcimb-14-1379831-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1ef/11091421/f2a1f7aea09d/fcimb-14-1379831-g007.jpg

相似文献

1
The impact of Sangju Qingjie Decoction on the pulmonary microbiota in the prevention and treatment of chronic obstructive pulmonary disease.桑菊清肺汤对慢性阻塞性肺疾病防治中肺部微生物群的影响。
Front Cell Infect Microbiol. 2024 Apr 30;14:1379831. doi: 10.3389/fcimb.2024.1379831. eCollection 2024.
2
Human Umbilical Cord Mesenchymal Stem Cells Improve Lung Function in Chronic Obstructive Pulmonary Disease Rat Model Through Regulating Lung Microbiota.人脐带间充质干细胞通过调节肺微生物群改善慢性阻塞性肺疾病大鼠模型的肺功能
Stem Cells. 2024 Apr 15;42(4):346-359. doi: 10.1093/stmcls/sxae007.
3
The lower airways microbiome and antimicrobial peptides in idiopathic pulmonary fibrosis differ from chronic obstructive pulmonary disease.特发性肺纤维化的下呼吸道微生物组和抗菌肽与慢性阻塞性肺疾病不同。
PLoS One. 2022 Jan 6;17(1):e0262082. doi: 10.1371/journal.pone.0262082. eCollection 2022.
4
Therapeutic Effects of Lifei Decoction in a Murine Model of COPD Induced by LPS and Cigarette Smoke.麻杏石甘汤联合参麦注射液治疗小儿支气管肺炎的临床疗效及对免疫功能的影响
Int J Chron Obstruct Pulmon Dis. 2024 Apr 18;19:957-967. doi: 10.2147/COPD.S449521. eCollection 2024.
5
Gut microbiota modulation and anti-inflammatory properties of Xuanbai Chengqi decoction in septic rats.玄柏承气汤对脓毒症大鼠肠道菌群调节及抗炎作用的研究。
J Ethnopharmacol. 2021 Mar 1;267:113534. doi: 10.1016/j.jep.2020.113534. Epub 2020 Nov 1.
6
The lung tissue microbiota of mild and moderate chronic obstructive pulmonary disease.轻度和中度慢性阻塞性肺疾病的肺组织微生物组。
Microbiome. 2018 Jan 9;6(1):7. doi: 10.1186/s40168-017-0381-4.
7
The Bufei Jianpi Formula Improves Mucosal Immune Function by Remodeling Gut Microbiota Through the SCFAs/GPR43/NLRP3 Pathway in Chronic Obstructive Pulmonary Disease Rats.补肺健脾方通过 SCFAs/GPR43/NLRP3 通路改善 COPD 大鼠肠道黏膜免疫功能。
Int J Chron Obstruct Pulmon Dis. 2022 Jun 1;17:1285-1298. doi: 10.2147/COPD.S359428. eCollection 2022.
8
Diversity of Fungi and Bacteria in Bronchoalveolar Lavage Fluid during Development of Chronic Obstructive Pulmonary Disease.慢性阻塞性肺疾病发展过程中支气管肺泡灌洗液中真菌和细菌的多样性
Jpn J Infect Dis. 2022 Nov 22;75(6):560-568. doi: 10.7883/yoken.JJID.2022.153. Epub 2022 Jul 29.
9
Analysis of the airway microbiota of healthy individuals and patients with chronic obstructive pulmonary disease by T-RFLP and clone sequencing.应用 T-RFLP 和克隆测序技术分析健康个体和慢性阻塞性肺疾病患者的气道微生物群。
PLoS One. 2013 Jul 9;8(7):e68302. doi: 10.1371/journal.pone.0068302. Print 2013.
10
Long-Term Erythromycin Treatment Alters the Airway and Gut Microbiota: Data from Chronic Obstructive Pulmonary Disease Patients and Mice with Emphysema.长期红霉素治疗改变气道和肠道微生物群:来自慢性阻塞性肺疾病患者和肺气肿小鼠的数据。
Respiration. 2024;103(8):461-479. doi: 10.1159/000538911. Epub 2024 Apr 26.

引用本文的文献

1
Intranasal administration of and its derived extracellular vesicles alleviate LPS-induced acute lung injury.经鼻给药及其衍生的细胞外囊泡可减轻脂多糖诱导的急性肺损伤。
Microbiol Spectr. 2024 Oct 29;12(12):e0210824. doi: 10.1128/spectrum.02108-24.

本文引用的文献

1
Reprogramming of Treg cells in the inflammatory microenvironment during immunotherapy: a literature review.免疫治疗中炎症微环境中 Treg 细胞的重编程:文献综述。
Front Immunol. 2023 Sep 11;14:1268188. doi: 10.3389/fimmu.2023.1268188. eCollection 2023.
2
The impact of concurrent bacterial lung infection on immunotherapy in patients with non-small cell lung cancer: a retrospective cohort study.同期细菌性肺部感染对非小细胞肺癌患者免疫治疗的影响:一项回顾性队列研究。
Front Cell Infect Microbiol. 2023 Aug 29;13:1257638. doi: 10.3389/fcimb.2023.1257638. eCollection 2023.
3
Optimal compatibility proportional screening of Trichosanthis Pericarpium - Trichosanthis Radix and its anti - Inflammatory components effect on experimental zebrafish and coughing mice.
瓜蒌-天花粉的最佳兼容性比例筛选及其抗炎成分对实验性斑马鱼和咳嗽小鼠的作用。
J Ethnopharmacol. 2024 Jan 30;319(Pt 1):117096. doi: 10.1016/j.jep.2023.117096. Epub 2023 Aug 25.
4
Imbalance of gut microbiota is involved in the development of chronic obstructive pulmonary disease: A review.肠道微生物群落失衡与慢性阻塞性肺疾病的发生发展有关:综述。
Biomed Pharmacother. 2023 Sep;165:115150. doi: 10.1016/j.biopha.2023.115150. Epub 2023 Jul 8.
5
Lung and Gut Microbiome in COPD.慢性阻塞性肺疾病中的肺部和肠道微生物群
J Pers Med. 2023 May 8;13(5):804. doi: 10.3390/jpm13050804.
6
Data on lung and intestinal microbiome after air pollution exposure in ageing rats.老年大鼠暴露于空气污染后肺部和肠道微生物组的数据。
Data Brief. 2023 Feb 23;47:109004. doi: 10.1016/j.dib.2023.109004. eCollection 2023 Apr.
7
Effects of Sangju Honey on Oral Squamous Carcinoma Cells.桑菊蜂蜜对口腔鳞状癌细胞的影响。
J Cancer Prev. 2022 Dec 31;27(4):239-246. doi: 10.15430/JCP.2022.27.4.239.
8
Identification of potential anti-pneumonia pharmacological components of et Rhizoma after the treatment with Gan An He Ji oral liquid.感冒合剂口服液治疗后莪术潜在抗肺炎药理成分的鉴定
J Pharm Anal. 2022 Dec;12(6):839-851. doi: 10.1016/j.jpha.2022.07.004. Epub 2022 Aug 5.
9
Lung microbiome composition and bronchial epithelial gene expression in patients with COPD versus healthy individuals: a bacterial 16S rRNA gene sequencing and host transcriptomic analysis.慢性阻塞性肺疾病患者与健康个体的肺部微生物群组成及支气管上皮基因表达:细菌16S rRNA基因测序和宿主转录组分析
Lancet Microbe. 2021 Jul;2(7):e300-e310. doi: 10.1016/S2666-5247(21)00035-5. Epub 2021 Apr 23.
10
Characteristics of the sputum microbiome in COPD exacerbations and correlations between clinical indices.COPD 加重期痰液微生物组特征及其与临床指标的相关性。
J Transl Med. 2022 Feb 5;20(1):76. doi: 10.1186/s12967-022-03278-x.